A critical discovery in cancer study is emerging with the use of VHH fragments to reactivate dysfunctional p53. This crucial tumor suppressor protein is frequently inactivated in many types of malignancies, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research